Rocket Lab's Order Book Tops 100 Missions — but Rising Yields Are Calling the Tune
Published on 10/07/2026 at 21:31 | Editorial boerse-global.de
Space may be infinite. The capital needed to reach it is not — and on Wednesday, that distinction mattered more than any launch manifest.
Rocket Lab shares fell 4.7% to EUR 63.60 as a wave of rate anxiety swept through growth equities. The move had nothing to do with the company itself: no operational misstep, no guidance cut, no lost contract. Instead, climbing US Treasury yields, firming energy costs and uncertainty over the Federal Reserve's next move combined to sour sentiment toward capital-hungry businesses. The 10-year yield pushing toward 5.35% and crude testing USD 102 a barrel were enough to send investors retreating from risk.
The pain was sector-wide. SpaceX, Redwire and Intuitive Machines all saw their share prices turn red, with media reports describing a broad selloff across space stocks. For Rocket Lab, the pullback extends a correction that has left the stock roughly 52% below its 52-week high of EUR 133.80.
Fundamentals Tell a Different Story
Strip away the macro noise and the operating picture looks considerably brighter. Last week the company locked in the largest commercial Electron launch contract in its history — a multi-year arrangement with Japan's Synspective covering 20 additional Electron flights, to be spread annually from 2028 through 2031. That deal pushed Rocket Lab's total launch backlog past 100 missions, and lifted its overall order book to USD 2.36 billion in the second quarter of 2026, a jump of 137%.
Reliability has kept pace with demand. On 26 September, Rocket Lab completed its 97th Electron mission, delivering Synspective's 13th StriX satellite into low Earth orbit at an altitude of 559 kilometers. It marked the company's 18th launch of 2026 — evidence that cadence is accelerating and customers are actively buying the service.
Should investors sell immediately? Or is it worth buying Rocket Lab?
Synspective's commitment now stands at 47 missions through 2031, a vote of confidence in a launch vehicle that has flown 96 times in total.
The Neutron Question Hangs Over Everything
None of that resolves the central challenge facing Rocket Lab: the heavy-lift Neutron rocket. Competing for mega-constellations and large payloads requires serious lift capacity, and developing it is expensive. CEO Peter Beck has acknowledged that the launch window at the end of the year is narrowing — a timeline that leaves little room for slippage.
That tension explains the company's move to acquire Iridium. The logic is straightforward: Iridium's roughly USD 500 million in annual adjusted EBITDA would flip Rocket Lab's current USD 80 million EBITDA loss into a gain of about USD 420 million. It is an attempt to buy operating stability before Neutron ever reaches the pad — and to avoid diluting shareholders further while the development bills pile up.
Behind the scenes, competition for government money is intensifying as well. Rocket Lab has filed a protest with the US Government Accountability Office over NASA's award of a USD 700 million Mars communications contract to Blue Origin. The message is clear: no one in this industry can afford to cede lucrative public contracts without a fight.
Wall Street Stays on Board
Analysts remain largely constructive despite the selloff. Citigroup initiated coverage on 1 October with a buy rating and a USD 105 price target, underscoring confidence in the longer-term trajectory.
Still, the road ahead demands patience. As long as rate fears dominate the macro backdrop, any delay to the Neutron schedule is likely to be punished swiftly. Rocket Lab is building infrastructure for the 21st century — but investors along for the ride must be prepared for the volatility of a richly valued stock.
Ad
Rocket Lab Stock: New Analysis - 7 October
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
